pembrolizumab,lenvatinib
merck,eisai
['lenva', 'rcc,(-irccs),(-srcc),(-urcc)', 'pembro']
pembrolizumab/lenvatinib combo shows promise in frontline nccrcc #esmo22 #urology #urologist 
Expert clinical analysis. Practice advice. Policy perspectives.